DISEASE AREAS

What we diagnose

BLOOD

Seek a confident and actionable diagnosis

ACCESSIBLE ANSWERS

Our comprehensive assessment approach
Overview

Blood cancers affect the production and function of your blood cells and often start in your bone marrow. In most cases, the normal blood cell development process is interrupted by uncontrolled growth of an abnormal type of blood cell. These cancerous cells prevent your blood from performing vital functions, like fighting off infection or clotting.

Advances

We have made strides in the diagnosis and treatment for leukemia, lymphoma, and myeloma. The medical community is innovating new methods to treat these conditions swiftly and effectively. Unlike radiation and chemotherapy, targeted therapies match with your molecular profile to fight disease effectively while trying to minimize change to normal cells.

How Genoptix helps

COMPASS®, our comprehensive assessment approach for bone marrow and blood workups, provides definite answers for patients with abnormal blood cell shape or production. Combining results from a range of relevant markers, we provide a confident diagnosis—and your doctor handles the rest.

Breast

Turn uncertainty into answers

ACCESSIBLE ANSWERS

Definitive results to identify treatment options
Overview

Breast cancer is the second most common cancer among women in the U.S. The chance of a woman having breast cancer during her lifetime is about one in eight.1 However, thanks to widespread early detection and effective treatment, the condition has a relatively low mortality rate.

Advances

Scientists and researchers are rapidly developing new ways to diagnose and treat breast cancers. Targeted therapies include drugs that target HER2, anti-angiogenesis drugs, and more.

How Genoptix helps

NexCourse Breast combines results for a range of markers, including HER2, ER/PR, and Ki67 expression to deliver definitive answers about your course of treatment. NexCourse Breast results can help your doctor predict which treatments you are likely to respond to and which may be ineffective or toxic.

Lung

Understand your prognosis

ACCESSIBLE ANSWERS

An improved path to treatment
Overview

Lung cancers are thought to develop over many years, starting with imperceptible precancerous changes in the lung. Over time, these cells develop, proliferate, and grow into a mass. There are two broad categories for lung cancer: Small-Cell and Non-Small Cell (NSCLC), which are treated very differently.

Advances

Over the past 20 years, the medical community has made exciting strides in understanding the specific mutations that cause NSCLC. And thanks to advances in research and treatment, our approach to these cases has changed. There are new ways to tackle lung cancer, improvements in radiation techniques, and targeted therapies based on a patient’s molecular profile.

How Genoptix helps

Using powerful molecular tests targeting specific markers and Next-Generation Sequencing, NexCourse® NSCLC can help your doctor predict which treatments you are likely to respond to and which may be ineffective or toxic. NexCourse NSCLC informs decisive treatments.

COLORECTAL

Determine your best course of treatment

ACCESSIBLE ANSWERS

A better way to choose your therapy
Overview

Colorectal cancer is the third most common cancer in the U.S. Most colorectal cancers start as a polyp, a growth in the inner lining of the colon or rectum, and grow toward the center.2

Advances

In the past 20 years, the medical community has made major breakthroughs in the treatment of colorectal cancer. After decades of limited treatment options, survival-boosting drugs came on the market, followed by monoclonal antibodies, a new generation of drugs that specifically target and starve out tumors.

How Genoptix helps

NexCourse Colorectal helps your healthcare provider decide what course of treatment to take by predicting which treatments you are likely to respond to and which may be ineffective or toxic.

MELANOMA/SKIN

Identifying the best course of treatment

ACCESSIBLE ANSWERS

Accessing advances in melanoma therapies
Overview

Melanoma begins in the melanocytes, which produce the pigment melanin. These cells are what cause freckles and moles on the skin, as well as suntans. In its early stages, melanoma can almost always be cured—but can progress and metastasize quickly.

Advances

In the past decades, advances have been made in melanoma treatment. There are specific drugs that target cells with changes in proteins and genes, including the BRAF, NRAS, and c-KIT genes.

How Genoptix helps

The Genoptix Melanoma Molecular Profile helps your healthcare provider decide what course of treatment to take. Using Next-Generation Sequencing, our Melanoma Molecular Profile can help your doctor predict which treatments you are likely to respond to and which may be ineffective or toxic.

GENERAL DISEASE INFORMATION

References

Information Source Material
  1. Breast Cancer Facts and Figures (2013-2014) – American Cancer Society
  2. Colorectal Cancer Facts and Figures (2013-2014) – American Cancer Society